PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog

Journal of Nuclear Medicine

Volumn 53, Issue 6, 2012, Pages 947-952

  Dijkgraaf, Ingrid ^a   Franssen, Gerben M ^a   McBride, William J ^b   D'Souza, Christopher A ^b   Laverman, Peter ^a   Smith, Charles J ^c,d   Goldenberg, David M ^b,e   Oyen, Wim J G ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IMMUNOMEDICS INC   (United States)

^c University of Missouri   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

Author keywords

Aluminum chloride; Bombesin; GRPR; PET; Radiofluorination

Indexed keywords

GASTRIN RELEASING PEPTIDE RECEPTOR; NOTA 8 AOC BOMBESIN[7-14]AMIDE F 18; NOTA 8 AOC BOMBESIN[7-14]AMIDE GA 68; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PURIFICATION; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY CLEARANCE; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIOACTIVITY; TUMOR XENOGRAFT;

ANIMALS; BINDING, COMPETITIVE; BOMBESIN; CELL LINE, TUMOR; FLUORINE RADIOISOTOPES; HUMANS; ISOTOPE LABELING; MALE; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RECEPTORS, BOMBESIN; TISSUE DISTRIBUTION;

EID: 84861911687     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.100891     Document Type: Article

References (29)

1. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-1694.
2. Markwalder R, Reubi JC. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res. 1999;59:1152-1159. (Pubitemid 29135980)
3. 125I-[D-TYR(6), beta-Ala(11), Phe(13), Nle(14)] bombesin(6-14). Clin Cancer Res. 2002;8:1139-1146.
4. Sun B, Halmos G, Schally AV, Wang X, Martinez M. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate. 2000;42:295-303. (Pubitemid 30104573)
5. Xiao D, Wang J, Hampton LL, Weber HC. The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. Gene. 2001;264:95-103. (Pubitemid 32195492)
6. Jensen RT, Battey JF, Spindel ER, Benya RV. International Union of Pharmacology. LXVIII.Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev. 2008;60:1-42. (Pubitemid 351439216)
7. Moody TW, Crawley JN, Jensen RT. Pharmacology and neurochemistry of bombesin-like peptides. Peptides. 1982;3:559-563. (Pubitemid 12026678)
8. Varvarigou A, Bouziotis P, Zikos C, Scopinaro F, De Vincentis G. Gastrin-releasing peptide (GRP) analogues for cancer imaging. Cancer Biother Radiopharm. 2004;19:219-229. (Pubitemid 38685120)
9. 86Y-DOTA-(Pro 1,Tyr 4)-bombesin(1-14). Bioconjug Chem. 2007;18:724-730.
10. 68Ga-labeled bombesin(6-14) analog. J Nucl Med. 2005;46:691-699.
11. Visser EP, Disselhorst JA, Brom M, et al. Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med. 2009;50:139-147.
12. 18F radiolabeling for PET. J Nucl Med. 2009;50:991-998.
13. Rogers BE, Bigott HM, McCarthy DW, et al. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. Bioconjug Chem. 2003;14:756-763. (Pubitemid 36875435)
14. 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl Med Biol. 2003;30:101-109.
15. 111In- labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nucl Med. 2003;44:823-831.
16. 2] targeting vector for positron emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues. Proc Natl Acad Sci USA. 2007;104:12462-12467.
17. Laverman P, McBride WJ, Sharkey RM, et al. A novel facile method of labeling octreotide with 18F-fluorine. J Nucl Med. 2010;51:454-461.
18. 18F-labeled hapten peptide in mice with human tumor xenografts. Mol Cancer Ther. 2010;9:1019-1027.
19. 18F chelation. Bioconjug Chem. 2011;22:1793-1803.
20. Fanti S, Nanni C, Ambrosini V, Gross MD, Rubello D, Farsad M. PET in genitourinary tract cancers. Q J Nucl Med Mol Imaging. 2007;51:260-271. (Pubitemid 47189064)
21. -. Biochem Biophys Res Commun. 1988;155:1194-1200.
22. Maina T, Nock BA, Zhang H, et al. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs. J Nucl Med. 2005;46:823-830.
23. 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. J Nucl Med. 2011;52:470-477.
24. Schroeder RP, Müller C, Reneman S, et al. A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues. Eur J Nucl Med Mol Imaging. 2010;37:1386-1396.
25. 111In-labelled bombesin analogues for molecular imaging of prostate tumours. Eur J Nucl Med Mol Imaging. 2007;34:1228-1238.
26. 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J Nucl Med. 2006;47:1144-1152.
27. 99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:247-258.
28. Zhang H, Schuhmacher J, Waser B, et al. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. Eur J Nucl Med Mol Imaging. 2007;34:1198-1208. (Pubitemid 47296770)
29. 18F labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjug Chem. 2010;21:1331-1340.